ALLT insider buying and SEC filings, explained
Allot Ltd. · CIK 1365767
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$682K
Planned sales (10b5-1)
$210K
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Nov 2, 2026 | Sale | Inbar Charash (General Counsel) sold 555 shares at about $8.50 ($5K). Holdings down 2% to 27,453 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 3, 2026, 10:56 AM ET |
| Aug 28, 2026 | Sale | Boaz Grossman (Senior Vice President R&D) sold 4,000 shares at $7.80 ($31K). Holdings down 2% to 182,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 31, 2026 |
| Aug 21, 2026 | Sale | Boaz Grossman (Senior Vice President R&D) sold 6,000 shares at $7.45 ($45K). Holdings down 3% to 186,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 24, 2026 |
| Aug 18, 2026 | Planned (10b5-1) | Gili Groner (Chief Human Resources Officer) sold 26,666 shares at about $7.86 ($210K), marked as a 10b5-1 plan trade. Holdings down 31% to 59,467 shares. | SEC filing Filed Aug 19, 2026 |
| Aug 6, 2026 | Sale | Eyal David Harari (CEO) sold 29,111 shares at about $7.64 ($222K). Holdings down 3% to 1,099,118 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 10, 2026 |
| Aug 3, 2026 | Sale | Inbar Charash (General Counsel) sold 556 shares at about $7.80 ($4K). Holdings down 2% to 28,008 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 4, 2026 |
| Jun 15, 2026 | Sale | Mark Shteiman (Chief Product Officer) sold 2,000 shares at $7.50 ($15K). Holdings down 1% to 212,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 16, 2026 |
| Jun 1, 2026 | Sale | Noam Lelah (SVP Customer Success & Ops) sold 21,000 shares at $8.48 ($178K). Holdings down 11% to 176,250 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 2, 2026 |
| May 21–22, 2026 | Sale | Mark Shteiman (Chief Product Officer) sold 11,000 shares between May 21 and May 22 at about $7.49 ($82K). Holdings down 5% to 214,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 26, 2026 |
| May 20, 2026 | Sale | Boaz Grossman (Senior Vice President R&D) sold 5,000 shares at $7.37 ($37K). Holdings down 3% to 192,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 21, 2026 |
| May 19, 2026 | Sale | Mark Shteiman (Chief Product Officer) sold 5,000 shares at $7.32 ($37K). Holdings down 2% to 225,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 20, 2026 |
| May 18, 2026 | Sale | Mark Shteiman (Chief Product Officer) sold 3,000 shares at about $7.13 ($21K). Holdings down 1% to 230,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 19, 2026 |
| May 1, 2026 | Sale | Inbar Charash (General Counsel) sold 556 shares at $7.40 ($4K). Holdings down 2% to 28,564 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 4, 2026 |
6 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow ALLT in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.